NEET-PG 2013 - Community Medicine Practice Questions

Q: What is a limitation of the case fatality rate?

Time period not specified. ***Time period not specified*** - The **case fatality rate (CFR)** is sometimes presented without a clear time frame, making it difficult to compare across different studies or diseases. - A CFR calculated over **24 hours** is vastly different from one calculated over **30 days** or **one year**, yet both could be presented simply as "CFR" *Not useful in acute infectious disease* - The CFR is highly **useful** in acute infectious diseases, as it directly measures the **severity** and immediate impact of an outbreak. - It helps public health officials understand the **lethality** of an infectious agent and aids in resource allocation and intervention strategies. *Not related to virulence* - **Case fatality rate** is directly related to **virulence**, as it reflects the proportion of affected individuals who die from the disease. - A higher CFR indicates a more **virulent pathogen** or a more severe disease process. *It is not related to survival rate* - The **case fatality rate** is inherently linked to the **survival rate**; they are complementary measures. - If the CFR is X%, then the associated survival rate is (100 - X)%, representing the proportion of cases that do not die from the disease.

Q: Which of the following statements about incidence is false?

Does not include unit of time. ***Does not include unit of time*** - This statement is false because **incidence** is defined as the number of **new cases** of a disease over a specific period of time in a population at risk. - Therefore, it inherently includes a **unit of time** (e.g., per year, per month), making this option incorrect as a characteristic of incidence. *It is a rate* - **Incidence is a rate** because it quantifies the speed at which new cases of a disease occur within a population. - It expresses the number of new events (cases) per unit of population at risk over a specified time period. *Numerator includes new cases* - The **numerator of incidence** specifically counts the number of **new cases** of a disease that develop during a defined observation period. - This distinguishes it from prevalence, which includes all existing cases. *Denominator includes population at risk* - The **denominator for incidence** comprises the **population at risk** of developing the disease during the observation period. - Individuals who already have the disease or are immune are typically excluded from the denominator.

Q: India started 2-dose vaccination strategy for measles, in -

2010. ***2010*** - India implemented the **two-dose measles vaccination strategy** as part of its Universal Immunization Program starting in **2010**. - This decision was based on recommendations to improve immunity and reduce measles incidence, moving from a single-dose to a more effective **two-dose schedule**. *2008* - While important immunization initiatives were ongoing, the specific policy of a **two-dose measles vaccination strategy** had not yet been introduced in India during 2008. - At this time, the focus was primarily on ensuring high coverage of the **first dose** of measles vaccine. *2009* - The year 2009 saw continued efforts to strengthen the Universal Immunization Program, but the official launch of the **two-dose measles vaccination strategy** in India occurred later. - Discussions and planning for the transition were likely underway, but implementation began in the subsequent year. *2011* - By 2011, the **two-dose measles vaccination strategy** was already being implemented across India, having been introduced in 2010. - This year marked a period of expanding coverage and consolidation of the new 2-dose schedule rather than its initial introduction.

Q: Which of the following vaccines is not typically given in disaster situations?

Influenza. ***Influenza*** - **Influenza vaccination** is generally **NOT a priority** in acute disaster response and emergency vaccination campaigns. - While influenza can spread in crowded conditions, routine disaster response protocols focus on **immediately life-threatening and epidemic-prone diseases** rather than seasonal respiratory infections. - Influenza vaccination requires **cold chain maintenance** and repeated doses, making it logistically challenging in emergency settings. - WHO and SPHERE guidelines do not list influenza among priority vaccines for disaster situations unless there is a specific ongoing outbreak. *Cholera* - **Oral cholera vaccine (OCV)** is increasingly recommended by WHO for disaster settings with **high cholera risk**, particularly in areas with poor water and sanitation. - Modern OCVs (like Shanchol and Euvichol) have improved **cost-effectiveness** and logistics, making them viable for mass campaigns. - Used in conjunction with **WASH interventions** (water, sanitation, hygiene) for comprehensive cholera control. *Measles* - **Measles vaccination** is the **highest priority** vaccine in disaster response, particularly for children aged 6 months to 15 years. - Its **extreme contagiousness** (R0 = 12-18) and high mortality in malnourished populations make it critical. - WHO recommends measles vaccination within the **first days** of a disaster response in displacement settings. *Tetanus* - **Tetanus toxoid** (often as Td or DT) is essential in disasters involving injuries, floods, earthquakes, or debris. - Protects against **_Clostridium tetani_** infection from contaminated wounds. - Part of standard **wound management protocols** in emergency medical care.

Q: Which of the following best defines the concept of 'Quality of Life'?

Subjective feeling of well being. ***Subjective feeling of well being*** - **Quality of Life** is primarily a **subjective measure**, reflecting an individual's personal perception of their well-being and satisfaction with various aspects of their life. - It encompasses physical health, psychological state, social relationships, personal beliefs, and their relationship to their environment. *Standard of living* - **Standard of living** typically refers to the degree of wealth and material comfort available to a person or community. - This is an **objective, economic measure** and does not fully capture the subjective, multi-dimensional aspects of well-being. *Level of living* - The **level of living** is closely related to the standard of living, focusing on the actual conditions of life experienced by individuals, often in terms of material possessions, housing, and access to services. - Like standard of living, it is more about **objective and measurable aspects** of life rather than subjective feelings. *None of the above* - This option is incorrect because "Subjective feeling of well being" accurately defines **Quality of Life**. - **Quality of Life** is a complex, multi-faceted concept that integrates both objective and subjective factors, with the subjective feeling of well-being being central to its definition.

Q: In the context of disease screening, which type of lead time is most beneficial for effective screening?

Long lead time is beneficial for screening. ***Long lead time is beneficial for screening*** - **Long lead time** provides a greater window of opportunity between disease detection by screening and clinical symptom onset - This extended asymptomatic detectable phase allows for **early intervention** when treatments are most effective - Longer lead time correlates with improved prognosis and potential prevention of severe outcomes - Essential criterion for effective screening programs per **Wilson-Jungner criteria** *Short lead time* - Limited time between disease detectability and clinical symptoms - Reduces screening effectiveness as disease progresses rapidly - Minimal opportunity for beneficial early intervention *Both short and long lead times are beneficial* - Only **long lead time** is beneficial for screening programs - Short lead time actually limits screening effectiveness - Screening benefit is directly proportional to duration of asymptomatic detectable phase *Lead time has no impact on screening effectiveness* - **Lead time is crucial** for determining screening program effectiveness - Directly impacts the window for early detection and intervention - Without adequate lead time, screening loses its preventive value

Q: Dukoral is:

Oral cholera vaccine. ***Oral cholera vaccine*** - Dukoral is a **killed oral whole-cell vaccine** against *Vibrio cholerae* O1 and O139, often combined with a recombinant B subunit of cholera toxin. - It provides protection against **cholera**, an acute diarrheal illness caused by bacterial infection of the small intestine. *Oral rotavirus vaccine* - Oral rotavirus vaccines (e.g., Rotarix, RotaTeq) provide protection against **rotavirus**, the most common cause of severe diarrhea in infants and young children. - These vaccines are usually given in multiple doses to infants and are distinct from cholera vaccines. *Oral typhoid vaccine* - An oral typhoid vaccine, such as Ty21a, is used for the prevention of **typhoid fever**, caused by *Salmonella Typhi*. - It is a **live attenuated vaccine** administered in several doses over a week, differing significantly from Dukoral's mechanism and target. *Ready to use therapeutic food* - **Ready-to-use therapeutic food (RUTF)** is a high-energy, micronutrient-rich paste used for the treatment of **severe acute malnutrition (SAM)**, especially in children. - It is a nutritional intervention, not a vaccine, and helps in weight gain and recovery for malnourished individuals.

Q: What is the annual infection rate of tuberculosis?

Percentage of new patients positive for tuberculin test. ***Percentage of new patients positive for tuberculin test*** - The **annual infection rate of tuberculosis (AIRT)** is defined as the percentage of individuals (typically children aged 1-9 years) who show **tuberculin conversion** (from negative to positive) in a given year. - Among the given options, this is the **closest representation** as it focuses on **newly infected individuals** rather than prevalent cases. - AIRT is a key epidemiological indicator reflecting **ongoing transmission** and the **annual risk of tuberculous infection** in a community. - This measure helps assess TB control program effectiveness and disease burden. *Percentage of total patients positive for tuberculin test* - This represents the **prevalence of tuberculosis infection** in the population, including both old and new infections. - It does not specifically measure the **annual rate of acquiring new infections**, which is what AIRT captures. *Percentage of sputum positive total patients* - This indicates the **prevalence of active, infectious pulmonary tuberculosis** in a population. - It refers to individuals with **active TB disease** who are shedding bacteria in sputum, not latent infection detected by tuberculin testing. *Percentage of sputum positive new patients* - This represents the **incidence of new, active, infectious tuberculosis cases** (case detection rate). - While important for TB surveillance, it measures **active disease** rather than **infection rate** detected by tuberculin skin test.

Q: According to the immunization schedule, how many doses of influenza vaccine should children under 9 years of age receiving the vaccine for the first time typically receive?

2 doses at 4 weeks interval. ***2 doses at 4 weeks interval*** - Children **under 9 years of age** receiving the influenza vaccine for the **first time** require **two doses** administered at least **4 weeks (28 days) apart**. - This two-dose priming schedule is essential to ensure adequate immune response and protection against circulating influenza strains. - This recommendation is consistent across **IAP (Indian Academy of Pediatrics)** and **CDC guidelines**. - Children 9 years and older, and younger children who have been previously vaccinated, require only **1 dose annually**. *3 doses at 4 weeks interval* - The standard protocol for influenza vaccination does **not involve three doses**. - A three-dose schedule is typically seen with vaccines like **Hepatitis B**, **DTaP**, or **Hib**, but not for influenza. *2 doses at 4 weeks interval with a booster dose for high-risk children* - While high-risk children (chronic lung disease, heart disease, immunocompromised) are priority groups for influenza vaccination, the schedule remains **two initial doses** for first-time recipients under 9 years. - There is **no additional booster dose** beyond the two-dose series within the same influenza season, even for high-risk children. - Subsequent years require only **1 dose annually**. *None of the options* - This is incorrect as the standard recommendation is clearly established in immunization guidelines. - The **two-dose schedule at 4-week intervals** for first-time recipients under 9 years is well-documented by IAP and international guidelines.

Q: Infectivity period of chickenpox is ?

1 day before and 4 days after appearance of rash. ***1 day before and 4 days after appearance of rash*** - The infectivity period of **chickenpox (varicella)** begins approximately **1-2 days (24-48 hours) before the rash appears**. - It extends until **all lesions have crusted over**, which typically occurs around **5-6 days after rash onset**, though some sources cite **4-5 days**. - This option represents the **commonly accepted timeframe** taught in Indian medical curricula and NEET PG examinations. *4 days before and 5 days after appearance of rash* - The **pre-rash infectivity period is too long** in this option; chickenpox is infectious for only **1-2 days before rash**, not 4 days. - While the "5 days after" is medically accurate, the incorrect pre-rash duration makes this option wrong. *Only when scab falls* - This statement is **incorrect**; infectivity starts much earlier, **1-2 days before the rash appears**. - By the time scabs fall, the person is **no longer infectious**, as crusted lesions contain non-infectious material. - This option ignores the critical **pre-rash and early rash infectious period**. *Entire incubation period* - The **incubation period** for chickenpox is usually **10-21 days**, during which the individual is **not infectious** for most of this time. - Infectivity begins only in the **last 1-2 days of incubation** (just before rash onset) and continues into the eruptive phase, not for the entire duration.

Question 1

What is a limitation of the case fatality rate?

Accepted Answer

Time period not specified

Answer

Not useful in acute infectious disease

Answer

Not related to virulence

Answer

It is not related to survival rate

Question 2

Which of the following statements about incidence is false?

Accepted Answer

Does not include unit of time

Answer

It is a rate

Answer

Numerator includes new cases

Answer

Denominator includes population at risk

Question 3

India started 2-dose vaccination strategy for measles, in -

Accepted Answer

2010

Answer

2008

Answer

2009

Answer

2011

Question 4

Which of the following vaccines is not typically given in disaster situations?

Accepted Answer

Influenza

Answer

Measles

Answer

Cholera

Answer

Tetanus

Question 5

Which of the following best defines the concept of 'Quality of Life'?

Accepted Answer

Subjective feeling of well being

Answer

Standard of living

Answer

Level of living

Answer

None of the above

Question 6

In the context of disease screening, which type of lead time is most beneficial for effective screening?

Accepted Answer

Long lead time is beneficial for screening

Answer

Short lead time

Answer

Both short and long lead times are beneficial

Answer

Lead time has no impact on screening effectiveness

Question 7

Dukoral is:

Accepted Answer

Oral cholera vaccine

Answer

Oral rotavirus vaccine

Answer

Oral typhoid vaccine

Answer

Ready to use therapeutic food

Question 8

What is the annual infection rate of tuberculosis?

Accepted Answer

Percentage of new patients positive for tuberculin test

Answer

Percentage of total patients positive for tuberculin test

Answer

Percentage of sputum positive total patients

Answer

Percentage of sputum positive new patients

Question 9

According to the immunization schedule, how many doses of influenza vaccine should children under 9 years of age receiving the vaccine for the first time typically receive?

Accepted Answer

2 doses at 4 weeks interval

Answer

2 doses at 4 weeks interval with a booster dose for high-risk children

Answer

3 doses at 4 weeks interval

Answer

None of the options

Question 10

Infectivity period of chickenpox is ?

Accepted Answer

1 day before and 4 days after appearance of rash

Answer

Only when scab falls

Answer

Entire incubation period

Answer

4 days before and 5 days after appearance of rash

NEET-PG 2013 — Community Medicine